Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
FFAR2 encodes a member of the GP40 family of G protein-coupled receptors that are clustered together on chromosome 19. Additionally we are shipping FFAR2 Kits (5) and FFAR2 Proteins (5) and many more products for this protein.
Showing 10 out of 83 products:
Human Polyclonal FFAR2 Primary Antibody for IF, ELISA - ABIN1535675
Grimwood, Gordon, Olsen, Terry, Schmutz, Lamerdin, Hellsten, Goodstein, Couronne, Tran-Gyamfi, Aerts, Altherr, Ashworth, Bajorek, Black, Branscomb, Caenepeel, Carrano, Caoile, Chan, Christensen et al.: The DNA sequence and biology of human chromosome 19. ... in Nature 2004
Human Polyclonal FFAR2 Primary Antibody for FACS, IF (p) - ABIN1713521
Kobayashi, Mikami, Kimura, Kamiyama, Morikawa, Yokoi, Kasuno, Takahashi, Taniguchi, Iwano: Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-α-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells. in Biochemical and biophysical research communications 2017
Compared with the control group, the densitometric quantification and mean density of GPR43 and ChAT proteins, and expression of GPR43 and CHAT genes, were significantly decreased in the patients with mixed refractory constipation.
a single dose of soluble fibre was able to significantly reduce airway inflammation in stable asthma by downregulating GPR43 and GPR41 (show FFAR3 Antibodies)
Short-chain fatty acids lowered TNF-alpha (show TNF Antibodies)-induced MCP-1 (show CCL2 Antibodies) expression by reducing phosphorylation of p38 MAPK (show MAPK14 Antibodies) and JNK (show MAPK8 Antibodies) in a GPR41 (show FFAR3 Antibodies)/GRP43-dependent manner in renal cortical epithelial cells.
FFA2 processes mediated by Gi signaling, whereas, in concert with blockade by the Gq/G11 (show STK19 Antibodies) inhibitor FR900359, the inability of AZ1729 to mimic or regulate propionate-mediated release of GLP-1 (show GCG Antibodies) from mouse colonic preparations defined this physiological response as an end point transduced via activation of Gq/G11 (show STK19 Antibodies).
the results of mutagenesis studies based on the crystal structure of hFFA1 bound to TAK (show CDK9 Antibodies)-875 at 2.3 A resolution to identify important residues for orthosteric agonist 6e inducing FFA2 activation.
Although both agonist and antagonist ligands contain negatively charged carboxylates that interact with two key positively charged arginine residues in transmembrane domains V and VII (show TH Antibodies) of FFA2, there are clear differences in how these interactions occur.
FFAR2 signaling occurs by divergent G protein pathways.
GPR3 agonism potentiates insulin secretion in isolated islets.
GPR43 expression is reduced in monocytes upon siRNA-knockdown of XBP1 (show XBP1 Antibodies), while A549 cells overexpressing XBP1 (show XBP1 Antibodies) displayed elevated GPR43 levels.
FFAR2 is a potential therapeutic target of T1 diabetes, representing a link between immune response and glucose homeostasis.
Gestational glucose tolerance in WT mice, but not Ffar2-/- mice improved while on antibiotics. Gestational glucose tolerance worsened in Ffar2-/- mice during a second pregnancy. Maternal Ffar2 expression had no effect on the growth rates and glucose and glucose tolerance in the offspring.
A Western diet could aggravate the inflammatory colitis process; the activation of the GPR43 receptor pathway could be used as a new strategy to treat Crohn's Disease patients.
Data (including data from studies in knockout mice) suggest Ffar2 expression in pancreatic beta-cells plays role in gestational glucose homeostasis; this mechanism involves gut microbiome (which contributes to plasma short-chain fatty acid levels).
High fat diet fed GPR43 KO mice develop glucose intolerance due to a defect in insulin (show INS Antibodies) secretion, reduced beta-cell mass and expression of differentiation genes. GPR3 (show GPR3 Antibodies) agonism potentiates insulin (show INS Antibodies) secretion.
GPR-43-deficient mice show a greatly decreased inflammatory reaction to knee injection of monosodium urate crystals in a mouse model of gout.
FFAR2 is expressed in pancreatic beta cells and mediates an inhibition of insulin (show INS Antibodies) secretion by coupling to Gi-type G proteins.
These findings establish GPR43 as a sensor for excessive dietary energy, thereby controlling body energy utilization while maintaining metabolic homoeostasis.
Data from transgenic mice suggest that Ffar2/Gpr43 and Ffar3/Gpr41 (show FFAR3 Antibodies) both act as sensors for short-chain fatty acids in enteroendocrine cells; Ffar2/Gpr43 appears to play this role alone in enteric leukocytes and Ffar3/Gpr41 (show FFAR3 Antibodies) alone in enteric neurons.
This gene encodes a member of the GP40 family of G protein-coupled receptors that are clustered together on chromosome 19. The encoded protein is a receptor for short chain free fatty acids and may be involved in the inflammatory response and in regulating lipid plasma levels.
G protein-coupled receptor 43
, G-protein coupled receptor 43
, free fatty acid activated receptor 2
, leukocyte-specific STAT-induced GPCR